TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Paralell Pharma Oy
Closing information (x1000 EUR)
Closing information | 2016/12 | 2015/12 | 2014/12 |
Turnover |
1,363
|
1,484
|
1,466 |
Financial expenses |
1
|
0 | |
Earnings before taxes |
404
|
113
|
497 |
Total assets |
1,391
|
1,650
|
1,867 |
Current assets |
185
|
258
|
287 |
Current liabilities |
42
|
52
|
72 |
Equity capital |
1,349
|
1,597
|
1,795 |
- share capital |
3
![]() |
3
![]() |
3 |
Financial ratios
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Solvency |
97.0%
|
96.8%
|
96.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
29.6%
|
7.6%
|
33.9% |
Return on assets (ROA) |
6.9%
|
26.6% | |
Current ratio |
440.5%
|
496.2%
|
398.6% |
Return on equity (ROE) |
29.9%
|
7.1%
|
27.7% |
Change turnover |
-121
|
18
|
229 |
Change turnover % |
-8%
|
1%
|
19% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2016/12 | 2015/12 | 2014/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.